XML 80 R66.htm IDEA: XBRL DOCUMENT v3.24.0.1
FAIR VALUE MEASUREMENTS - Narrative (Details)
 12 Months Ended
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]      
Contingent consideration, liability $ 288,657,000 $ 306,927,000 $ 359,021,000
Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Cumulative Amount 5,100,000    
Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Cumulative Amount 15,100,000    
Gain on Sale of Investments 5,400,000   $ 30,500,000
Loss on Sale of Investments   10,000,000  
Venture Capital Investment Fund      
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]      
Investment owned, fair value 5,200,000 $ 3,900,000  
Committed capital 17,500,000    
Committed capital callable $ 12,100,000    
Weighted Average | Product Development and Other Milestone-based Payments | Measurement Input, Probability of Success      
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]      
Contingent consideration liability, measurement input 0.89 0.91  
Weighted Average | Product Development and Other Milestone-based Payments | Measurement Input, Present-value Factor      
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]      
Contingent consideration liability, measurement input 0.058 0.062  
Foreign Exchange Forward      
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]      
Derivative, notional amount $ 39,500,000 $ 22,300,000  
Derivative, fair value 0 0  
Thrive, Ashion and OmicEra | Fair Value      
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]      
Contingent consideration, liability $ 288,700,000 $ 306,800,000